Tumor necrosis factor expression by human ovarian carcinoma in vivo.
Tumor necrosis factor (TNF) is a cytokine produced by monocytes and other cells with selective cytolytic activity against some but not all tumor cells. Cellular resistance to the cytolytic effects of TNF has been reported to be associated with autocrine production of TNF by the target cells. The purpose of this study was to determine whether or not human tumors produce tumor necrosis factor in vivo. Ovarian carcinoma tissue from 25 patients with ovarian carcinoma was examined for the presence of TNF. Four of 5 ascites fluid specimens and tissue sections of 16 of 20 patients were positive for TNF by immunoperoxidase staining. The source of the immunoreactive protein was further examined by in situ hybridization studies. TNF mRNA was detectable in each of the ascites specimens and 7 of 16 tissue sections that were positive by immunoperoxidase staining. These findings suggest that TNF is produced by some human tumors in vivo and that the association between TNF production and resistance to TNF antitumor action may be clinically relevant.
Takeyama
H
H
Laboratory of Clinical Pharmacology, Dana Farber Cancer Institute, Boston, Massachusetts 02115.
Wakamiya
N
N
O'Hara
C
C
Arthur
K
K
Niloff
J
J
Kufe
D
D
Sakarai
K
K
Spriggs
D
D
D001201:Ascites / Q000473:pathology; D002460:Cell Line; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D009693:Nucleic Acid Hybridization; D010051:Ovarian Neoplasms / Q000473:pathology*; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis / Q000235:genetics*
D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha